Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma (MM) after Prior Proteasome Inhibitor (PI) and Immunomodulatory Drug (IMiD... von Clemens, P.L, Yan, X, Puchalski, T, Lokhorst, H.M, Lonial, S, Losic, N, Khan, I, Jansson, R, Ahmadi, T, Lantz, K, Zhou, H, Xu, X.S

Volltext

Exposure-Response Relationship of Daratumumab Efficacy and Safety in Patients with Relapsed or Refractory Multiple Myeloma (MM) after Prior Proteasome Inhibitors (PIs) and Immunomo... von Xu, X.S, Yan, X, Puchalski, T, Lonial, S, Lokhorst, H.M, Liu, K, Khan, I, Jansson, R, Ahmadi, T, Perez Ruixo, J.J, Clemens, P.L, Zhou, H

Volltext

Preparing to Undertake the System Safety Analysis von Clemens, P.L.

Volltext

S823 RANDOMIZED, OPEN‐LABEL, NON‐INFERIORITY, PHASE 3 STUDY OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) DARATUMUMAB (DARA) ADMINISTRATION IN PATIENTS WITH RELAPSED OR REFRACTORY M... von Mateos, M.‐V., Nahi, H., Legiec, W., Grosicki, S., Vorobyev, V., Spicka, I., Hungria, V., Korenkova, S., Bahlis, N., Flogegard, M., Blade, J., Moreau, P., Kaiser, M., Iida, S., Laubach, J., Ahmadi, T., Clemens, P.L., Masterson, T., Lantz, K., O’Rourke, L., Heuck, C., Peng, L., Parasrampuria, D.A., Yuan, Z., Qi, M., Usmani, S.Z.

Volltext

Clemens Responds von Clemens, P.L.

Volltext

Zero-Injury Workdays: An effective metric? von Clemens, P.L.

Volltext

More on the Cost off Safety von Clemens, P.L.

Volltext

Economy-Based Countermeasure Decisions: A tutorial for SH&E professionals von Kilgore, Clark, Clemens, P.L.

Volltext

INVESTIGATIVE THOROUGHNESS von Clemens, P.L.

Volltext

CLEMENS RESPONDS von Clemens, P.L.

Volltext

S823 RANDOMIZED, OPEN‐LABEL, NON‐INFERIORITY, PHASE 3 STUDY OF SUBCUTANEOUS (SC) VERSUS INTRAVENOUS (IV) DARATUMUMAB (DARA) ADMINISTRATION IN PATIENTS WITH RELAPSED OR REFRACTORY M... von Mateos, M.‐V., Nahi, H., Legiec, W., Grosicki, S., Vorobyev, V., Spicka, I., Hungria, V., Korenkova, S., Bahlis, N., Flogegard, M., Blade, J., Moreau, P., Kaiser, M., Iida, S., Laubach, J., Ahmadi, T., Clemens, P.L., Masterson, T., Lantz, K., O’Rourke, L., Heuck, C., Peng, L., Parasrampuria, D.A., Yuan, Z., Qi, M., Usmani, S.Z.

Volltext

A REAL READER SERVICE von Clemens, P.L.

Volltext

Absence of apoptosis in hypoxic cervical carcinoma von Varia, M.A., Clemens, P.L., Chou, S.C., Raleigh, J.A.

Volltext

LET'S DELIGHT IN THE ATTENTION von Clemens, P.L.

Volltext

LOOK NO FURTHER FOR MOTIVATION von Clemens, P.L.

Volltext

WHOLE SYSTEM RISK IS THE KEY von Clemens, P.L.

Volltext

LET'S STRIVE FOR ACCURACY von Clemens, P.L.

Volltext

DIDN'T DELIVER ON PROMISE von Clemens, P.L.

Volltext

Many Hazard Analyses Conceal Whole-System Risk von CLEMENS, P.L.

Volltext

System Safety in Design Practice: Two Work Models Compared von CLEMENS, P.L.

Volltext